
In this episode of NCPDPunscripted, NCPDP sits down with Christian Tadrus, R.Ph, PharmaD, FASCP, AE-C, NSC and Mindy Smith. R.Ph, MHA, to talk about leadership, progress, and what’s next for NCPDP.

In this episode of NCPDPunscripted, NCPDP sits down with Christian Tadrus, R.Ph, PharmaD, FASCP, AE-C, NSC and Mindy Smith. R.Ph, MHA, to talk about leadership, progress, and what’s next for NCPDP.

Investigators find modest improvements in body weight at week 26 for CT-868 compared with the placebo.

At 72 weeks, patients who took the highest dose of orforglipron lost an average of 27.3 lb.

With more than half the population struggling to access medical care, community pharmacies are emerging as unexpected heroes in the health care delivery system.

Pharmacists can now showcase their skills within the health care industry by counseling patients and continuing to learn and grow with them.

As part of a retrospective study, researchers explored the association between BMI and osteoporosis risk as outcomes evolve from adolescence to adulthood.

Sit-to-stand transitions may lower diastolic blood pressure in postmenopausal women with overweight or obesity, offering a simple way to reduce cardiovascular risk.

Researchers gathered a group of adolescent-serving clinicians and asked them about their confidence in helping patients with abortion access.

Fremanezumab-vfrm (Ajovy) receives FDA approval for the prevention of episodic migraine for patients aged 6 to 17 years.


New research shows metformin's inconsistent neuroprotective effects against Alzheimer disease, challenging its role in diabetes management for cognitive health.

Patients with type 2 diabetes and moderate cardiovascular risk had a higher rate of major heart-related events when treated with sulfonylureas.

Among rural community pharmacies in the US, researchers explored pneumococcal immunization services, the processes used to identify patient eligibility, and the barriers to vaccine administration.

FDA approves Biktarvy for HIV treatment in patients not virologically suppressed, enhancing options for those restarting antiretroviral therapy.

Researchers conducted a systematic review to determine the effectiveness of pharmacists in promoting vaccine uptake for protection against the most prominent infectious diseases.

After the certification of a new stroke center in respective communities, researchers compared the stroke outcomes of Black patients with those of White patients.

Since the COVID-19 pandemic, pharmacists are reevaluating career paths and calling for greater flexibility, support, and opportunities for professional growth.

In the study, tirzepatide (Mounjaro) improved measures of A1c, weight, renal function, and all-cause mortality.

Hashim Zaibak, PharmD, CEO of Hayat Pharmacy, discusses the ongoing narratives surrounding vaccine hesitancy as well as his thoughts on the best ways of addressing the phenomenon.

This episode highlights how being intentional about adding value strengthens relationships and shapes effective leadership in everyday situations.

When independent and retail storefronts close across the country, creating a lack of pharmacy services in the community, pharmacy deserts arise.

In this retrospective cohort study, researchers investigated the association between formulary coverage for disease-modifying therapies and the potential for MS relapse.

The FDA also recommended a scheduling action for 7-hydroxymitragynine (7-OH), with data showing the drug binds to opioid receptors.

Novavax’s H5N1 avian influenza vaccine candidate shows a robust immune response with 1- and 2-dose intranasal or intramuscular administration for nonhuman primates.

Hashim Zaibak, PharmD, CEO of Hayat Pharmacy, discusses how immunization services at his pharmacy locations have evolved since the COVID-19 pandemic.

The updated label removes the requirement that inclisiran should be used on top of or in combination with statin therapies.

Researchers explore whether or not exposure to e-cigarette or cannabis content on social media leads to increased use among adolescents.

For biosimilar, generic, and branded medications, Cencora researchers conducted a report detailing growth in formulary exclusions among the 3 largest pharmacy benefit managers in the US.

Many treatments for hemophilia A and B are administered via intravenous infusions, so the approval offers a subcutaneous injection for the treatment for patients 12 years and older.

Community pharmacies emerge as key players in early cognitive decline detection, offering vital screening tools and support for at-risk patients.